Tautomycin inhibits phosphatase-dependent transformation of the rat kidney mineralocorticoid receptor

The binding of aldosterone (ALDO) to the mineralocorticoid receptor (MR) induces a conformational change of the protein referred to as 'transformation'. This feature can be evidenced in vivo by the capacity of the MR to interact with chromatin, and in vitro by the ability of the MR to bind...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado: 1998
Materias:
rat
DNA
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03037207_v144_n1-2_p119_PiwienPilipuk
http://hdl.handle.net/20.500.12110/paper_03037207_v144_n1-2_p119_PiwienPilipuk
Aporte de:
id paper:paper_03037207_v144_n1-2_p119_PiwienPilipuk
record_format dspace
spelling paper:paper_03037207_v144_n1-2_p119_PiwienPilipuk2025-07-30T18:06:43Z Tautomycin inhibits phosphatase-dependent transformation of the rat kidney mineralocorticoid receptor Mineralocorticoid receptor Protein phosphatases Receptor transformation Tautomycin (rat kidney) acid phosphatase aldosterone alkaline phosphatase levamisole mineralocorticoid receptor phosphoprotein phosphatase tautomycin transcription factor animal tissue article complex formation conformational transition controlled study cytosol enzyme activity enzyme inhibition kidney male nonhuman phosphorylation priority journal protein conformation rat reaction time signal transduction temperature dependence Aldosterone Alkaline Phosphatase Animals Antibiotics, Antifungal Cell Nucleus Cellulose Centrifugation, Density Gradient Chromatography, Ion Exchange Cytoplasm DNA Dose-Response Relationship, Drug Kidney Kinetics Levamisole Male Phosphoprotein Phosphatase Protein Conformation Pyrans Rats Rats, Sprague-Dawley Receptors, Mineralocorticoid Spiro Compounds Temperature The binding of aldosterone (ALDO) to the mineralocorticoid receptor (MR) induces a conformational change of the protein referred to as 'transformation'. This feature can be evidenced in vivo by the capacity of the MR to interact with chromatin, and in vitro by the ability of the MR to bind to DNA strands or to shift the sedimentation coefficient (S) to lower values. The transformation process allows MR to work as a transcription factor after interacting with specific sequences of DNA. The signal transduction pathway for the MR transformation remains unknown. As a first step towards elucidating the mechanism of steroid-dependent MR transformation, we asked if the MR-signaling pathway is affected by the phosphorylation status of the MR-heterocomplex, and how that pathway may be regulated. Incubation of preformed [3H]ALDO-MR complex with bovine intestinal alkaline phosphatase led to an increase in the rate of MR-transformation (measured as 9.4-5.4S shift). This alkaline phosphatase-dependent MR transformation was inhibited by the specific alkaline phosphatase-type inhibitor levamisole, and was not evident in incubations performed with acid phosphatases. A direct correlation between the DNA-cellulose binding capacity of the [3H]ALDO-MR complex and the percentage of transformed 5.4S MR form was also observed. When rat kidney cytosol was incubated in the absence of both exogenous phosphatase and stabilizing agents (such as molybdate or vanadate), MR transformation also took place, in a time- and temperature-dependent process. In contrast with the inhibitory effect observed upon alkaline phosphatase-promoted transformation, levamisole was unable to inhibit the endogenous transforming activity of MR, suggesting that an endogenous phosphatase other than those which belong to the alkaline-type may be responsible for that transformation. Tautomycin, a polyketide produced by the soil bacteria Streptomyces which inhibits serine/threonine phosphatases of the PP1/PP2A subgroup, was able to inhibit the endogenous phosphatase activity in a concentration-dependent form (K(i(app))=7.35 nM). These results support the idea that the endogenous renal activity involved in the regulation of rat kidney MR transformation may be a protein phosphatase which belongs to the PP1/PP2A subgroup. Copyright (C) 1998 Elsevier Science Ireland Ltd. 1998 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03037207_v144_n1-2_p119_PiwienPilipuk http://hdl.handle.net/20.500.12110/paper_03037207_v144_n1-2_p119_PiwienPilipuk
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Mineralocorticoid receptor
Protein phosphatases
Receptor transformation
Tautomycin (rat kidney)
acid phosphatase
aldosterone
alkaline phosphatase
levamisole
mineralocorticoid receptor
phosphoprotein phosphatase
tautomycin
transcription factor
animal tissue
article
complex formation
conformational transition
controlled study
cytosol
enzyme activity
enzyme inhibition
kidney
male
nonhuman
phosphorylation
priority journal
protein conformation
rat
reaction time
signal transduction
temperature dependence
Aldosterone
Alkaline Phosphatase
Animals
Antibiotics, Antifungal
Cell Nucleus
Cellulose
Centrifugation, Density Gradient
Chromatography, Ion Exchange
Cytoplasm
DNA
Dose-Response Relationship, Drug
Kidney
Kinetics
Levamisole
Male
Phosphoprotein Phosphatase
Protein Conformation
Pyrans
Rats
Rats, Sprague-Dawley
Receptors, Mineralocorticoid
Spiro Compounds
Temperature
spellingShingle Mineralocorticoid receptor
Protein phosphatases
Receptor transformation
Tautomycin (rat kidney)
acid phosphatase
aldosterone
alkaline phosphatase
levamisole
mineralocorticoid receptor
phosphoprotein phosphatase
tautomycin
transcription factor
animal tissue
article
complex formation
conformational transition
controlled study
cytosol
enzyme activity
enzyme inhibition
kidney
male
nonhuman
phosphorylation
priority journal
protein conformation
rat
reaction time
signal transduction
temperature dependence
Aldosterone
Alkaline Phosphatase
Animals
Antibiotics, Antifungal
Cell Nucleus
Cellulose
Centrifugation, Density Gradient
Chromatography, Ion Exchange
Cytoplasm
DNA
Dose-Response Relationship, Drug
Kidney
Kinetics
Levamisole
Male
Phosphoprotein Phosphatase
Protein Conformation
Pyrans
Rats
Rats, Sprague-Dawley
Receptors, Mineralocorticoid
Spiro Compounds
Temperature
Tautomycin inhibits phosphatase-dependent transformation of the rat kidney mineralocorticoid receptor
topic_facet Mineralocorticoid receptor
Protein phosphatases
Receptor transformation
Tautomycin (rat kidney)
acid phosphatase
aldosterone
alkaline phosphatase
levamisole
mineralocorticoid receptor
phosphoprotein phosphatase
tautomycin
transcription factor
animal tissue
article
complex formation
conformational transition
controlled study
cytosol
enzyme activity
enzyme inhibition
kidney
male
nonhuman
phosphorylation
priority journal
protein conformation
rat
reaction time
signal transduction
temperature dependence
Aldosterone
Alkaline Phosphatase
Animals
Antibiotics, Antifungal
Cell Nucleus
Cellulose
Centrifugation, Density Gradient
Chromatography, Ion Exchange
Cytoplasm
DNA
Dose-Response Relationship, Drug
Kidney
Kinetics
Levamisole
Male
Phosphoprotein Phosphatase
Protein Conformation
Pyrans
Rats
Rats, Sprague-Dawley
Receptors, Mineralocorticoid
Spiro Compounds
Temperature
description The binding of aldosterone (ALDO) to the mineralocorticoid receptor (MR) induces a conformational change of the protein referred to as 'transformation'. This feature can be evidenced in vivo by the capacity of the MR to interact with chromatin, and in vitro by the ability of the MR to bind to DNA strands or to shift the sedimentation coefficient (S) to lower values. The transformation process allows MR to work as a transcription factor after interacting with specific sequences of DNA. The signal transduction pathway for the MR transformation remains unknown. As a first step towards elucidating the mechanism of steroid-dependent MR transformation, we asked if the MR-signaling pathway is affected by the phosphorylation status of the MR-heterocomplex, and how that pathway may be regulated. Incubation of preformed [3H]ALDO-MR complex with bovine intestinal alkaline phosphatase led to an increase in the rate of MR-transformation (measured as 9.4-5.4S shift). This alkaline phosphatase-dependent MR transformation was inhibited by the specific alkaline phosphatase-type inhibitor levamisole, and was not evident in incubations performed with acid phosphatases. A direct correlation between the DNA-cellulose binding capacity of the [3H]ALDO-MR complex and the percentage of transformed 5.4S MR form was also observed. When rat kidney cytosol was incubated in the absence of both exogenous phosphatase and stabilizing agents (such as molybdate or vanadate), MR transformation also took place, in a time- and temperature-dependent process. In contrast with the inhibitory effect observed upon alkaline phosphatase-promoted transformation, levamisole was unable to inhibit the endogenous transforming activity of MR, suggesting that an endogenous phosphatase other than those which belong to the alkaline-type may be responsible for that transformation. Tautomycin, a polyketide produced by the soil bacteria Streptomyces which inhibits serine/threonine phosphatases of the PP1/PP2A subgroup, was able to inhibit the endogenous phosphatase activity in a concentration-dependent form (K(i(app))=7.35 nM). These results support the idea that the endogenous renal activity involved in the regulation of rat kidney MR transformation may be a protein phosphatase which belongs to the PP1/PP2A subgroup. Copyright (C) 1998 Elsevier Science Ireland Ltd.
title Tautomycin inhibits phosphatase-dependent transformation of the rat kidney mineralocorticoid receptor
title_short Tautomycin inhibits phosphatase-dependent transformation of the rat kidney mineralocorticoid receptor
title_full Tautomycin inhibits phosphatase-dependent transformation of the rat kidney mineralocorticoid receptor
title_fullStr Tautomycin inhibits phosphatase-dependent transformation of the rat kidney mineralocorticoid receptor
title_full_unstemmed Tautomycin inhibits phosphatase-dependent transformation of the rat kidney mineralocorticoid receptor
title_sort tautomycin inhibits phosphatase-dependent transformation of the rat kidney mineralocorticoid receptor
publishDate 1998
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03037207_v144_n1-2_p119_PiwienPilipuk
http://hdl.handle.net/20.500.12110/paper_03037207_v144_n1-2_p119_PiwienPilipuk
_version_ 1840327502732460032